Australia markets closed

BELLUS Health Inc. (BLU)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
8.32+0.22 (+2.72%)
At close: 04:00PM EDT
8.48 +0.16 (+1.92%)
After hours: 06:08PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
16
16
15
26.7938
25.6969
Operating expenses
Research development
58,585
59,791
23,729
19,995
5,275
Selling general and administrative
14,843
14,263
9,735
6,680
2,503
Total operating expenses
72,686
73,300
32,957
26,132
7,299
Operating income or loss
-72,670
-73,284
-32,942
-26,105
-7,273
Interest expense
43
55
39
22.9662
3.671
Total other income/expenses net
2,524
1,683
179
-1,421
341.4022
Income before tax
-69,999
-71,423
-31,757
-26,385
-6,669
Income tax expense
-174
-199
-
-
0
Income from continuing operations
-69,825
-71,224
-31,757
-26,385
-6,669
Net income
-69,825
-71,224
-31,757
-26,385
-6,669
Net income available to common shareholders
-69,825
-71,224
-31,757
-26,385
-6,669
Basic EPS
-
-0.90
-0.54
-0.56
-0.21
Diluted EPS
-
-0.90
-0.54
-0.56
-0.21
Basic average shares
-
79,316
59,023
47,430
33,617
Diluted average shares
-
79,316
59,023
47,430
33,617
EBITDA
-
-71,175
-31,539
-26,241
-6,666